Nvidia enters with a minority stake in Doctolib to support Ai use
The European healthtech company relies on artificial intelligence to optimize the work of healthcare professionals
Quick Look
Nvidia acquires a minority stake in Doctolib, a leading European healthtech company, to support the development of artificial intelligence solutions for doctors and patients.
AI-generated summary
Why It Matters
Doctolib is a European platform providing digital services for healthcare professionals and patients. The company employs around 100 experts dedicated to developing artificial intelligence models.
Nvidia enters with a minority stake in the capital of Doctolib, the European company active in the health technology sector (healthtech) to support the further acceleration of the development of AI.
Doctolib, underlines a note, "is developing its own solutions and artificial intelligence models in Europe for healthcare professionals and patients". Its consultation assistant, which has already documented more than 12 million doctor visits, is based on a speech recognition model developed by its teams and specializes in medical vocabulary in different languages.
Doctolib has also developed Ai assistants that relieve healthcare professionals of numerous administrative tasks, including benefit coding, billing, secretarial work and document management. The company is also working on clinical decision support assistants, jointly developed with healthcare professionals. Today, 100 million patients and 580,000 healthcare professionals use Doctolib's services, while around 100 scientists, engineers and designers work on the development of its AI models and solutions.
Open Questions
- What is the economic size of Nvidia's investment?
